ArticleBioengineering & translational medicine2024

Highly efficient CRISPR/Cas9-mediated exon skipping for recessive dystrophic epidermolysis bullosa.

Alex du Rand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.